<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">00592</article-id><article-id pub-id-type="doi">10.7554/eLife.00592</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biophysics and Structural Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Native α-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2/VAMP2</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-1791"><name><surname>Diao</surname><given-names>Jiajie</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/><xref ref-type="aff" rid="aff4"/><xref ref-type="fn" rid="equal-contrib">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-3937"><name><surname>Burré</surname><given-names>Jacqueline</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="equal-contrib">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-3938"><name><surname>Vivona</surname><given-names>Sandro</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/><xref ref-type="aff" rid="aff4"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-1794"><name><surname>Cipriano</surname><given-names>Daniel J</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/><xref ref-type="aff" rid="aff4"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-3939"><name><surname>Sharma</surname><given-names>Manu</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="con5"/></contrib><contrib contrib-type="author" id="author-1793"><name><surname>Kyoung</surname><given-names>Minjoung</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/><xref ref-type="aff" rid="aff4"/><xref ref-type="fn" rid="pa1">‡</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-3940"><name><surname>Südhof</surname><given-names>Thomas C</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff4"/><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-1054"><name><surname>Brunger</surname><given-names>Axel T</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/><xref ref-type="aff" rid="aff4"/><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Molecular and Cellular Physiology</institution>, <institution>Stanford University</institution>, <addr-line><named-content content-type="city">Stanford</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Structural Biology</institution>, <institution>Stanford University</institution>, <addr-line><named-content content-type="city">Stanford</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Departments of Photon Sciences, and Neurology and Neurological Sciences</institution>, <institution>Stanford University</institution>, <addr-line><named-content content-type="city">Stanford</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution>Howard Hughes Medical Institute, Stanford University</institution>, <addr-line><named-content content-type="city">Stanford</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Jahn</surname><given-names>Reinhard</given-names></name><role>Reviewing editor</role><aff><institution>Max Planck Institute for Biophysical Chemistry</institution>, <country>Germany</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>brunger@stanford.edu</email> (ATB);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>tcs1@stanford.edu</email> (TCS)</corresp><fn fn-type="con" id="equal-contrib"><label>†</label><p>These authors contributed equally to this work</p></fn><fn fn-type="present-address" id="pa1"><label>‡</label><p>Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, Baltimore, United States</p></fn></author-notes><pub-date date-type="pub" publication-format="electronic"><day>30</day><month>04</month><year>2013</year></pub-date><pub-date pub-type="collection"><year>2013</year></pub-date><volume>2</volume><elocation-id>e00592</elocation-id><history><date date-type="received"><day>29</day><month>01</month><year>2013</year></date><date date-type="accepted"><day>25</day><month>03</month><year>2013</year></date></history><permissions><copyright-statement>© 2013, Diao et al</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Diao et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-00592-v1.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.00592.001</object-id><p>α-Synuclein is a presynaptic protein that is implicated in Parkinson's and other neurodegenerative diseases. Physiologically, native α-synuclein promotes presynaptic SNARE-complex assembly, but its molecular mechanism of action remains unknown. Here, we found that native α-synuclein promotes clustering of synaptic-vesicle mimics, using a single-vesicle optical microscopy system. This vesicle-clustering activity was observed for both recombinant and native α-synuclein purified from mouse brain. Clustering was dependent on specific interactions of native α-synuclein with both synaptobrevin-2/VAMP2 and anionic lipids. Out of the three familial Parkinson's disease-related point mutants of α-synuclein, only the lipid-binding deficient mutation A30P disrupted clustering, hinting at a possible loss of function phenotype for this mutant. α-Synuclein had little effect on Ca<sup>2+</sup>-triggered fusion in our reconstituted single-vesicle system, consistent with in vivo data. α-Synuclein may therefore lead to accumulation of synaptic vesicles at the active zone, providing a ‘buffer’ of synaptic vesicles, without affecting neurotransmitter release itself.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.00592.001">http://dx.doi.org/10.7554/eLife.00592.001</ext-link></p></abstract><abstract abstract-type="executive-summary"><object-id pub-id-type="doi">10.7554/eLife.00592.002</object-id><title>eLife digest</title><p>The central nervous system coordinates many different activities by sending instructions to large numbers of cells and, simultaneously, processing all the signals that are sent back to the brain. All these messages are carried by electrical pulses that travel along chains of neurons, with neurotransmitter molecules enclosed inside synaptic vesicles conveying the messages across the synapses between neurons. A protein called α-synuclein is thought to have a role in the transport of neurotransmitter molecules across synapses, but the details of its involvement are not fully understood.</p><p>Mutations in the gene that codes for α-synuclein, and also duplications and triplications of this gene, are known to lead to an increased risk of early onset Parkinson's disease, a condition where the central nervous system degenerates. Moreover, the Lewy bodies found in the neurons of patients with Parkinson's disease contain high concentrations of α-synuclein. Again, however, none of this is fully understood.</p><p>Diao et al. have shed new light on these questions by creating synthetic vesicles to mimic what happens in real synapses, and using optical microscopy to observe the behaviour of these vesicles. They found that native α-synuclein (and another set of membrane proteins) increases the availability of synthetic vesicles at the synapse by causing them to cluster together. In a second experiment, Diao et al. showed that native α-synuclein does not decrease calcium-triggered fusion between membranes, the process that releases neurotransmitter into the synaptic cleft. In contrast, it is known that pathogenic α-synuclein aggregates directly interfere with the release of the neurotransmitter molecules. Moreover, when Diao et al. used a particular mutant form of α-synuclein that is associated with Parkinson's disease, the vesicles did not form clusters. If these results are confirmed in vivo, the role played by native α-synuclein in the central nervous system, and the connection between α-synuclein and Parkinson's disease, will be much clearer.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.00592.002">http://dx.doi.org/10.7554/eLife.00592.002</ext-link></p></abstract><kwd-group kwd-group-type="author-keywords"><title>Author keywords</title><kwd>Parkinson's disease</kwd><kwd>synaptic terminals</kwd><kwd>alpha-synuclein</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>Howard Hughes Medical Institute</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Südhof</surname><given-names>Thomas C</given-names></name><name><surname>Brunger</surname><given-names>Axel T</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R37-MH63105</award-id><principal-award-recipient><name><surname>Brunger</surname><given-names>Axel T</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>NS077906</award-id><principal-award-recipient><name><surname>Südhof</surname><given-names>Thomas C</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Experiments on synthetic models of synaptic vesicles have shed new light on the role of the protein α-synuclein in the central nervous system.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>α-Synuclein (α-Syn) is an abundant presynaptic protein that is expressed throughout the central nervous system (CNS) and associated with synaptic vesicles (<xref ref-type="bibr" rid="bib42">Maroteaux et al., 1988</xref>; <xref ref-type="bibr" rid="bib31">Jensen et al., 1998</xref>). Pathologically, missense mutations (A30P, E46K, A53T) of α-Syn (<xref ref-type="bibr" rid="bib45">Polymeropoulos et al., 1997</xref>; <xref ref-type="bibr" rid="bib33">Kruger et al., 1998</xref>; <xref ref-type="bibr" rid="bib60">Zarranz et al., 2004</xref>) and duplications and triplications of the gene that encodes α-Syn (<xref ref-type="bibr" rid="bib51">Singleton et al., 2003</xref>; <xref ref-type="bibr" rid="bib14">Chartier-Harlin et al., 2004</xref>) are linked to early onset Parkinson's disease (PD). Moreover, Lewy bodies observed in Parkinson's disease, dementia with Lewy bodies, and other neurodegenerative diseases contain high concentrations of α-Syn aggregates (<xref ref-type="bibr" rid="bib53">Spillantini et al., 1997</xref>; <xref ref-type="bibr" rid="bib29">Hardy and Gwinn-Hardy, 1998</xref>; <xref ref-type="bibr" rid="bib52">Spillantini et al., 1998</xref>). In aqueous solution, α-Syn is a largely unfolded protein and has a propensity to aggregate in a nucleation-dependent manner, forming β-sheet rich amyloid-like fibrils (<xref ref-type="bibr" rid="bib50">Serpell et al., 2000</xref>; <xref ref-type="bibr" rid="bib61">Zhao et al., 2011</xref>; <xref ref-type="bibr" rid="bib8">Burré et al., In press</xref>). Fibrils, protofibrils and/or large oligomers are believed to be cytotoxic (<xref ref-type="bibr" rid="bib17">Conway et al., 2000</xref>; <xref ref-type="bibr" rid="bib28">Goldberg and Lansbury, 2000</xref>; <xref ref-type="bibr" rid="bib5">Bucciantini et al., 2002</xref>), and may be responsible, at least in part, for the neurodegeneration observed in diseases featuring Lewy bodies. Physiologically, α-Syn increases the rate of SNARE-complex formation at the synapse via binding to the SNARE protein synaptobrevin-2 (also called VAMP2, vesicle associated membrane protein 2) and to phospholipids (<xref ref-type="bibr" rid="bib7">Burré et al., 2010</xref>).</p><p>In adult canaries and zebra finches, α-Syn expression correlates with plasticity in the developing song control system (<xref ref-type="bibr" rid="bib16">Clayton and George, 1998</xref>). However, deletion of α-Syn in mice has been reported to show either no or very small and opposing effects on neurotransmitter release (<xref ref-type="bibr" rid="bib1">Abeliovich et al., 2000</xref>; <xref ref-type="bibr" rid="bib10">Cabin et al., 2002</xref>; <xref ref-type="bibr" rid="bib12">Chandra et al., 2004</xref>; <xref ref-type="bibr" rid="bib37">Liu et al., 2004</xref>; <xref ref-type="bibr" rid="bib58">Yavich et al., 2004</xref>; <xref ref-type="bibr" rid="bib56">Unger et al., 2006</xref>; <xref ref-type="bibr" rid="bib49">Senior et al., 2008</xref>; <xref ref-type="bibr" rid="bib7">Burré et al., 2010</xref>; <xref ref-type="bibr" rid="bib26">Garcia-Reitbock et al., 2010</xref>; <xref ref-type="bibr" rid="bib48">Scott et al., 2010</xref>; <xref ref-type="bibr" rid="bib2">Anwar et al., 2011</xref>). Similarly, overexpression of α-Syn either in transgenic mice or using stereotactic injections of adeno-associated virus have resulted in conflicting effects on neurotransmitter release, although chronic overexpression nearly always leads to neurodegeneration (<xref ref-type="bibr" rid="bib37">Liu et al., 2004</xref>; <xref ref-type="bibr" rid="bib36">Larsen et al., 2006</xref>; <xref ref-type="bibr" rid="bib7">Burré et al., 2010</xref>; <xref ref-type="bibr" rid="bib44">Nemani et al., 2010</xref>; <xref ref-type="bibr" rid="bib27">Gaugler et al., 2012</xref>).</p><p>Structurally, α-Syn is a 14-kDa protein composed of an amphipathic, positively charged 100 residue N-terminal domain with a lysine-rich N-terminus that binds reversibly to anionic membranes (<xref ref-type="bibr" rid="bib46">Rhoades et al., 2006</xref>), and a 40-residue highly acidic C-terminal domain that interacts with the N-terminal sequence of synaptobrevin-2 (<xref ref-type="bibr" rid="bib7">Burré et al., 2010</xref>). Recombinant, erythrocyte, and brain α-Syn is predominantly monomeric in solution with a smaller fraction of multimeric species, and is largely unstructured with a small (approximately 21–24%) helical contribution (<xref ref-type="bibr" rid="bib24">Fauvet et al., 2012</xref>; <xref ref-type="bibr" rid="bib8">Burré et al., 2013</xref>). At high concentrations (∼500 μM) and in the presence of β-octylglucoside, nuclear magnetic resonance spectra showed weak intramolecular NOEs in regions of α-helical propensity but no tertiary interactions, reminiscent of a molten globule (<xref ref-type="bibr" rid="bib57">Wang et al., 2011</xref>). The interaction with anionic lipids induces α-helicity in α-Syn, as revealed by CD spectroscopy (<xref ref-type="bibr" rid="bib18">Davidson et al., 1998</xref>; <xref ref-type="bibr" rid="bib32">Jo et al., 2000</xref>). Moreover, solution NMR studies, EPR analyses, calorimetry, and single molecule fluorescence resonance transfer experiments in the presence of SDS micelles and small unilamellar vesicles revealed that the N-terminal 100 residues form a broken amphiphatic α-helix upon binding to anionic lipids (<xref ref-type="bibr" rid="bib9">Bussell and Eliezer, 2003</xref>; <xref ref-type="bibr" rid="bib11">Chandra et al., 2003</xref>; <xref ref-type="bibr" rid="bib55">Ulmer et al., 2005</xref>; <xref ref-type="bibr" rid="bib30">Jao et al., 2008</xref>; <xref ref-type="bibr" rid="bib25">Ferreon et al., 2009</xref>; <xref ref-type="bibr" rid="bib38">Lokappa and Ulmer, 2011</xref>; <xref ref-type="bibr" rid="bib40">Maltsev et al., 2013</xref>). Binding of α-Syn to the membrane is transient, and the C-terminal 40 residues of α-Syn are unstructured and not bound to the membrane (<xref ref-type="bibr" rid="bib4">Bodner et al., 2009</xref>). N-terminal acetylation of α-Syn does not induce significant structure in recombinant α-Syn in solution (i.e., absence of detergents or lipids), but further enhances its binding to anionic membranes and induced α-helicity (<xref ref-type="bibr" rid="bib41">Maltsev et al., 2012</xref>). Although initially largely monomeric, purified brain α-Syn associates into partially folded multimers and aggregates in a time-dependent manner (<xref ref-type="bibr" rid="bib8">Burré et al., 2013</xref>). It is likely that these different monomeric and oligomeric states exist in an equilibrium in vivo, which is modulated by a variety of factors and interactions, such as membrane binding. This labile mixture of conformations provides a potential explanation for why α-Syn is so susceptible to pathological aggregation and fibril formation as observed in multiple neurodegenerative disorders (<xref ref-type="bibr" rid="bib20">Devine et al., 2011</xref>; <xref ref-type="bibr" rid="bib43">Martin et al., 2011</xref>).</p><p>To investigate the effect of native α-Syn on synaptic vesicle fusion, we employed a recently developed in vitro system (<xref ref-type="bibr" rid="bib34">Kyoung et al., 2011</xref>; <xref ref-type="bibr" rid="bib21">Diao et al., 2012a</xref>) that allowed us to measure the effect of α-Syn on Ca<sup>2+</sup>-triggered vesicle fusion with reconstituted neuronal SNAREs, synaptotagmin-1, and complexin-1 on a sub-sec timescale. We found that native α-Syn does not significantly affect the efficiency and kinetics of Ca<sup>2+</sup>-triggered synaptic protein-mediated fusion itself. Rather, α-Syn induces clustering of vesicles with reconstituted synaptobrevin-2 or with both reconstituted synaptobrevin-2 and synaptotagmin-1. The clustering effect is dependent on specific binding to both anionic lipid membranes and synaptobrevin-2 as revealed by deletion and mutagenesis studies, including the Parkinson's disease mutant A30P that disrupts lipid binding. Furthermore, clustering is induced by both recombinant and brain-purified native α-Syn, both of which are initially in a largely monomeric state in the absence of membranes. This clustering or lack thereof may account for the increase in SNARE-complex levels observed upon overexpression of native α-Syn (<xref ref-type="bibr" rid="bib7">Burré et al., 2010</xref>), and, conversely, the decrease in SNARE-complex assembly in αβγ-Syn triple knockout mice (<xref ref-type="bibr" rid="bib7">Burré et al., 2010</xref>).<boxed-text id="box1"><object-id pub-id-type="doi">10.7554/eLife.00592.003</object-id><label>Box 1.</label><caption><p>Definitions</p></caption><p><bold>v-vesicle</bold>: proteoliposome with reconstituted synaptobrevin-2 in all experiments except <xref ref-type="fig" rid="fig1 fig2 fig4">Figures 1, 2, and 4D</xref> where both synaptobrevin-2 and synaptotagmin-1 were reconstituted. We also refer to these vesicles as “synaptic-vesicle mimics”.</p><p><bold>t-vesicle</bold>: proteoliposome with reconstituted syntaxin-1A and SNAP-25A. We also refer to these vesicles as “plasma-membrane mimics”.</p><p><bold>v-/t-vesicle association</bold>: fluorescent spot arising from labeled v-vesicles (or small clusters of v-vesicles) that bind to a surface with immobilized t-vesicles, using the protocol described in the ‘Single vesicle-vesicle Ca<sup>2+</sup>-triggered fusion experiments’ section in ‘Materials and Methods’.</p><p><bold>v-/v-vesicle cluster</bold>: fluorescent spot arising from labeled v-vesicles that bind to a surface with immobilized v-vesicles, using the protocol described in the ‘Single-vesicle clustering experiments’ section in ‘Materials and Methods’.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.00592.003">http://dx.doi.org/10.7554/eLife.00592.003</ext-link></p></boxed-text></p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Native α-Syn has little effect on Ca<sup>2+</sup>-triggered synaptic-protein mediated v-/t-vesicle fusion</title><p>To address the question of whether native α-Syn influences Ca<sup>2+</sup>-triggered synaptic-protein mediated membrane fusion, we employed our recently developed in vitro single vesicle–vesicle fusion system using vesicles with reconstituted synaptic proteins (<xref ref-type="bibr" rid="bib34">Kyoung et al., 2011</xref>; <xref ref-type="bibr" rid="bib21">Diao et al., 2012a</xref>; <xref ref-type="bibr" rid="bib35">Kyoung et al., 2012</xref>). Free-floating ‘v-vesicles’ (with reconstituted synaptobrevin-2 and synaptotagmin-1) mimicked synaptic vesicles, while surface-immobilized ‘t-vesicles’ (with reconstituted syntaxin-1 and SNAP-25) mimicked the presynaptic plasma membrane (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). A defined volume of v-vesicle solution was incubated with t-vesicles together with complexin-1, establishing a metastable state at zero Ca<sup>2+</sup>. We tested the effect of recombinant α-Syn with our system by adding it to the v-vesicle incubation stage. For the v-vesicles that bound, native α-Syn had little effect on the efficiency (defined as the number of fusion events per docked v-vesicles) and the kinetics of Ca<sup>2+</sup>-triggered fusion upon injection of 500 μM Ca<sup>2+</sup> (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), and it did not alter the corresponding cumulative fusion distribution plot (<xref ref-type="fig" rid="fig1">Figure 1C</xref>).<fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.00592.004</object-id><label>Figure 1.</label><caption><title>Native α-Syn has no effect on Ca<sup>2+</sup> -triggered v-/t-vesicle fusion.</title><p>(<bold>A</bold>) Experimental scheme of our single v-/t-vesicle content mixing system (<xref ref-type="bibr" rid="bib34">Kyoung et al., 2011</xref>; <xref ref-type="bibr" rid="bib35">Kyoung et al., 2012</xref>), with improvements described in (<xref ref-type="bibr" rid="bib21">Diao et al., 2012a</xref>), and further modifications described in ‘Materials and methods’. (<bold>B</bold>) and (<bold>C</bold>) α-Syn has little effect on the probability of triggered vesicle fusion upon injection of 500 μM Ca<sup>2+</sup>. Panels show histograms of the occurrence (<bold>B</bold>) and the corresponding cumulative distribution (<bold>C</bold>) of Ca<sup>2+</sup>-triggered complete fusion (content mixing) in presence or absence of 2 μM α-Syn. In the absence of α-Syn, we observed 166 fusion events out of ∼2000 docked v-vesicles (identified as fluorescent spots that were present prior to Ca<sup>2+</sup> injection), whereas in the presence of α-Syn, we observed 84 fusion events out of ∼1300 docked v-vesicles within the observation period of 50 s. The time-binning was 1 s. Black lines are fits to bi-exponential decay functions over the entire observation period of 50 s. In the absence of α-Syn, the fitted function is f(t) = −0.0046 + 0.048 e<sup>-t/27.1</sup> + 0.26 e<sup>-t/0.58</sup>, whereas in the presence of α-Syn, the fitted function is f(t) = −0.001 + 0.064 e<sup>-t/15.4</sup> + 0.22 e<sup>-t/0.51</sup> with t in sec.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.00592.004">http://dx.doi.org/10.7554/eLife.00592.004</ext-link></p></caption><graphic xlink:href="elife-00592-fig1-v1"/></fig></p></sec><sec id="s2-2"><title>α-Syn induces v-vesicle clustering</title><p>Although native α-Syn showed no effect on Ca<sup>2+</sup>-triggered fusion activity, we noticed that α-Syn reduced the number of fluorescent spots that appeared when v-vesicles bound to immobilized t-vesicles during the incubation stage at zero Ca<sup>2+</sup> (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). However, the addition of native α-Syn produced the emergence of brighter spots between 1.5 and 6 a.u. in the fluorescence emission histogram (insert, <xref ref-type="fig" rid="fig2">Figure 2B</xref>), along with occasional very large fluorescent spots (black arrow, lower right image in <xref ref-type="fig" rid="fig2">Figure 2A</xref>). The major peak (&lt;1.5 a.u.) at low fluorescence intensity corresponds to single donor v-vesicles docked to the imaging surface, while the high intensity tail (&gt;2 a.u.) corresponds to small clusters of v-vesicles docked to the surface. In the presence of α-Syn, we thus observed a reduction of the single vesicle population and a concomitant increase of a population of vesicle clusters. We note that the same finite volume and concentration of individual v-vesicles was used during the incubation stage with and without native α-Syn. Thus, the observed decrease in the total number of fluorescent spots (referred to as ‘v-/t-vesicle associations’) in the presence of native α-Syn (<xref ref-type="fig" rid="fig2">Figure 2A</xref>) can be explained by a reduction of the number of free-floating particles by clustering of individual v-vesicles in the finite volume of the sample chamber (<xref ref-type="fig" rid="fig2">Figure 2C</xref>).<fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.00592.005</object-id><label>Figure 2.</label><caption><title>Native α-Syn decreases the number of v-/t-vesicle associations.</title><p>(<bold>A</bold>) Plotted is the number of content dye fluorescent spots in presence of 2 μM complexin-1 and with or without 2 μM α-Syn (tag-free construct); example images are shown in the lower two panels. Scoring (‘counts’) excluded the few very large fluorescent spots that appeared in the presence of α-Syn; an example is shown in the lower right panel, marked by a black arrow. Error bars are standard deviations from 10 random imaging locations within the same sample channel. *** indicates p&lt;0.001 by the Student's t-test. (<bold>B</bold>) Distribution of the fluorescence intensity of all fluorescent spots as shown in panel (<bold>A</bold>). In the presence of α-Syn, the number of low intensity fluorescent spots (up to 1.5 a.u.) decreased, which was accompanied by an increase in higher intensity fluorescent spots (see inset) due to the formation of v-vesicle clusters. The very large fluorescent spot (black arrow in the lower right image in panel (<bold>A</bold>)) was excluded in this distribution. (<bold>C</bold>) Illustration that clustering of v-vesicles induced by α-Syn reduces the effective number of fluorescent spots (corresponding to docked single or multiples of v-vesicles) in a finite volume since the starting concentration of individual v-vesicles was identical with and without α-Syn.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.00592.005">http://dx.doi.org/10.7554/eLife.00592.005</ext-link></p></caption><graphic xlink:href="elife-00592-fig2-v1"/></fig></p><p>We next confirmed the clustering activity of native α-Syn on v-vesicles with a different assay that was designed to directly probe the interaction between v-vesicles (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). One population of v-vesicles was anchored to an imaging surface, while the other population was free-floating. Both vesicle populations were labeled with spectrally distinct fluorescent lipid analogues allowing tracking of the location of the free-floating vesicles and assessment of the surface coverage of the immobilized vesicles, respectively. Interactions between both populations of v-vesicles were measured by counting the number of initially free-floating v-vesicles that bound to the immobilized v-vesicles. We refer to this quantity as ‘clustering’ between vesicles of the same type (v-/v-vesicle clustering). The protocol of this clustering experiment included an incubation step with native α-Syn followed by buffer exchange, in order to measure the interaction between immobilized v-vesicles with bound α-Syn and free-floating v-vesicles without α-Syn (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). This procedure prevented formation of the large fluorescent spots that we observed in the v-/t-vesicle fusion experiments, and it also reduced the likelihood of non-specific vesicle clustering by α-Syn oligomerization.<fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.00592.006</object-id><label>Figure 3.</label><caption><title>Native α-Syn induces clustering of synaptobrevin-2 v-vesicles.</title><p>(<bold>A</bold>) Experimental scheme of our single-vesicle assay for monitoring clustering of synaptobrevin-2 v-vesicles. A saturated layer of DiD-labeled v-vesicles with reconstituted synaptobrevin-2 was immobilized on an imaging surface via biotin/neutravidin interactions. Free-floating DiI-labeled vesicles with reconstituted synaptobrevin-2 were injected into the sample chamber (‘Materials and methods’). The number of v-/v-vesicle interactions (clustering) in presence or absence of α-Syn was determined by counting the number of spots arising from fluorescence emission of DiI upon excitation at 532 nm. (<bold>B</bold>) Experimental flow: 1. Immobilization of DiD-labeled v-vesicles on the imaging surface through biotin/neutravidin interactions. 2. Buffer exchange. 3. α-Syn incubation of the surface with immobilized DiD v-vesicles. 4. Buffer exchange, removing unbound or weakly bound α-Syn molecules. 5. Injection of DiI-labeled v-vesicles without α-Syn. Following another buffer exchange, the channels were imaged on the microscope.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.00592.006">http://dx.doi.org/10.7554/eLife.00592.006</ext-link></p></caption><graphic xlink:href="elife-00592-fig3-v1"/></fig></p><p>Using this clustering assay, we confirmed that native α-Syn increases the clustering of v-vesicles in a concentration-dependent manner (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). We note that the specified α-Syn concentration refers to the incubation stage with immobilized v-vesicles (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, middle panel). Subsequent to the incubation stage, a buffer exchange with α-Syn-free buffer was performed for 6 s which removed unbound α-Syn. Moreover, it is likely that the buffer exchange also removed some of the v-vesicle-bound α-Syn molecules since kinetic studies by NMR spectroscopy revealed that α-Syn binding to membranes is transient with exchanges occurring in the range of 1–10 s<sup>-1</sup> (<xref ref-type="bibr" rid="bib4">Bodner et al., 2009</xref>). Thus, the effective α-Syn concentration during the final clustering step (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, right panel) is lower than 2–20 μM, as only bound α-Syn is present at this stage. Indeed, as <xref ref-type="fig" rid="fig4">Figure 4A</xref> shows, v-vesicle clustering has not reached saturation at 2 μM α-Syn incubation concentration, so v-vesicles were not fully covered with α-Syn molecules at that particular α-Syn incubation concentration.<fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.00592.007</object-id><label>Figure 4.</label><caption><title>Native α-Syn (tag-free construct) promotes v-vesicle clustering by binding to both synaptobrevin-2 and anionic membranes.</title><p>(<bold>A</bold>) α-Syn increases the number of interacting DiI-labeled v-vesicles on the imaging surface in a concentration-dependent manner. Bar graph: quantitation of interacting vesicles. Bottom panel: representative fluorescence images of interacting vesicles on the imaging surface. Error bars are standard deviations from 15 random imaging locations in the sample channel obtained. (<bold>B</bold>) Number of interactions between free-floating and immobilized v-vesicles in presence of wildtype α-Syn and its mutant that does not bind to synaptobrevin-2 (α-Syn[1-95] with myc-tag) at indicated concentrations. (<bold>C</bold>) Purified α-Syn wildtype and α-Syn[1-95] (with myc-tag) expressed in bacteria were analyzed by SDS-PAGE and Coomassie staining. (<bold>D</bold>) Number of interactions in the presence of 20 μM α-Syn (myc-tag construct). At variance to panels (<bold>A</bold>, <bold>B</bold>, and <bold>C</bold>), both free-floating and immobilized v-vesicles were reconstituted with synaptobrevin-2 (Syb2), synaptotagmin-1 (Syt1), or both (Syb2/Syt1). Note, that the slight variation in the ‘absolute’ number of observed fluorescent spots between comparable experiments in panels (<bold>A</bold>, <bold>B</bold>, and <bold>D</bold>) arises mainly from tagged vs untagged versions of α-Syn, as well as from different liposome and imaging surface preparations. Yet, the ‘relative’ differences were statistically similar for different protein preparations. In all panels, error bars are standard deviations from 10 random imaging locations in the same sample channel, and *** indicates p&lt;0.001 by the Student's t-test.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.00592.007">http://dx.doi.org/10.7554/eLife.00592.007</ext-link></p></caption><graphic xlink:href="elife-00592-fig4-v1"/></fig></p><p>As another independent confirmation of v-vesicle clustering, a cryo-electron microscopy experiment revealed large v-vesicle clusters in the presence of native α-Syn (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Note, that the vesicle concentration used for the cryo-EM experiment was 100-fold higher and the effective α-Syn concentration was also higher than that used for the single-vesicle clustering experiments, explaining the formation of the fairly large clusters in the cryo-EM experiment at that concentration. V-vesicles clustering does not occur in the absence of α-Syn (<xref ref-type="bibr" rid="bib34">Kyoung et al., 2011</xref>) and is therefore specific to native α-Syn. It is also entirely dependent on the presence of synaptobrevin-2, as lack of synaptobrevin-2 (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), or truncation of C-terminal residues of α-Syn that bind to synaptobrevin-2 (<xref ref-type="bibr" rid="bib7">Burré et al., 2010</xref>) but do not participate in lipid binding of α-Syn (<xref ref-type="bibr" rid="bib7">Burré et al., 2010</xref>, <xref ref-type="bibr" rid="bib6">2012</xref>) significantly reduced clustering of v-vesicles (<xref ref-type="fig" rid="fig4">Figure 4B,C</xref>). Furthermore, clustering of v-vesicles depended on the presence of negatively charged (anionic) lipids (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, right most condition), which is known to induce α-helix formation in native α-Syn and lipid binding of α-Syn. As a control, and in agreement with previous studies (<xref ref-type="bibr" rid="bib18">Davidson et al., 1998</xref>; <xref ref-type="bibr" rid="bib32">Jo et al., 2000</xref>; <xref ref-type="bibr" rid="bib23">Eliezer et al., 2001</xref>), we observed α-helicity in the CD spectrum of native α-Syn in the presence of protein-free vesicles with the same lipid composition used for our fusion and v-vesicle clustering experiments (<xref ref-type="fig" rid="fig6">Figure 6</xref>). Taken together, our clustering experiments suggest that native α-Syn has to bind to both, synaptobrevin-2 and anionic lipids, in order to cluster v-vesicles, confirming the protein- and anionic-lipid specificity of this phenomenon.<fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.00592.008</object-id><label>Figure 5.</label><caption><title>Cryo-electron microscopy image of clusters of synaptobrevin-2 v-vesicles as induced by native α-Syn. Scale bar is 200 nm.</title><p>The dark feature is the holey carbon grid. In contrast, reconstituted v-vesicles in the absence of α-Syn do not form clusters (<xref ref-type="bibr" rid="bib34">Kyoung et al., 2011</xref>).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.00592.008">http://dx.doi.org/10.7554/eLife.00592.008</ext-link></p></caption><graphic xlink:href="elife-00592-fig5-v1"/></fig><fig id="fig6" position="float"><object-id pub-id-type="doi">10.7554/eLife.00592.009</object-id><label>Figure 6.</label><caption><title>Native α-Syn undergoes a conformational transition from a predominantly unstructured state in solution to an α-helical state upon binding to protein-free vesicles as measured by CD spectroscopy.</title><p>The protein-free vesicles had the same lipid composition as the v-vesicles used throughout this work. The molar protein-to-lipid ratio was 1:530, and tag-free wildtype α-Syn was used.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.00592.009">http://dx.doi.org/10.7554/eLife.00592.009</ext-link></p></caption><graphic xlink:href="elife-00592-fig6-v1"/></fig></p><p>In the next experiment, we asked if the inclusion of synaptotagmin-1 in the synaptobrevin-2 vesicles would alter v-vesicle clustering induced by native α-Syn (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). We found that v-vesicle clustering induced by native α-Syn was similar with and without synaptotagmin-1 within experimental error. Furthermore, v-vesicles with only reconstituted synaptotagmin-1 did not cluster, consistent with the requirement of synaptobrevin-2 for native α-Syn-induced v-vesicle clustering (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). For the remaining experiments we therefore used v-vesicles that only contained synaptobrevin-2.</p></sec><sec id="s2-3"><title>V-vesicle clustering ability of native α-Syn is reduced by the Parkinson's disease mutant A30P</title><p>To further investigate the membrane-binding role of native α-Syn on v-vesicle clustering, and to extend our findings to PD, we performed experiments with the three PD-related mutants A30P, E46K, and A53T (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). While all these mutants retain the ability to bind synaptobrevin-2, only A30P shows reduced membrane binding (<xref ref-type="bibr" rid="bib6">Burré et al., 2012</xref>). We measured the effect of these mutations on membrane-binding using a lipid flotation assay (<xref ref-type="fig" rid="fig7">Figure 7B</xref>), and on v-vesicle clustering using single vesicle microscopy (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). Out of the mutants tested, only A30P showed ∼ 50% decrease in membrane binding and v-vesicle clustering compared to native wildtype α-Syn. Thus, the effect of the three mutations in v-vesicle clustering correlated well with their effect on native α-Syn binding to PS-containing vesicles. This suggests that membrane-binding by native α-Syn is essential for its clustering activity.<fig id="fig7" position="float"><object-id pub-id-type="doi">10.7554/eLife.00592.010</object-id><label>Figure 7.</label><caption><title>V-vesicle clustering correlates with lipid binding of native α-Syn.</title><p>(<bold>A</bold>) Purification of α-Syn expressed in bacteria. Purified α-Syn wildtype and the three Parkinson's disease (PD)-related mutants A30P, E46K, and A53T (all tag-free constructs) were analyzed by SDS-PAGE and Coomassie staining. (<bold>B</bold>) Lipid binding of recombinant α-Syn wildtype, and of the PD mutants A30P, E46K, and A53T. α-Syn was incubated with negatively charged liposomes (30% phosphatidylserine, 70% phosphatidylcholine, or 100% phosphatidylcholine as control), and subjected to a flotation assay. Eight fractions were collected from top to bottom of the flotation gradient, and equal volumes of each fraction were separated by SDS-PAGE and immunoblotted for α-Syn. Top two fractions were defined as lipid-bound, and quantitated as percent of total α-Syn. Data shown are means ± SEM; n = 3. (<bold>C</bold>) Impaired lipid-binding of α-Syn decreases v-vesicle clustering. In order to measure vesicle clustering, the number of DiI-labeled v-vesicles that were docked to immobilized v-vesicles was counted, as illustrated in <xref ref-type="fig" rid="fig3">Figure 3</xref>. (<bold>D</bold>) Impaired lipid-binding of α-Syn increases the number of v-/t-vesicle associations. The number of fluorescent spots arising from labeled v-vesicles were counted that were docked to t-vesicles (immobilized to the imaging-surface), as illustrated in <xref ref-type="fig" rid="fig2">Figure 2</xref>, but in the presence of the specified α-Syn mutants without complexin-1. In all panels, error bars are standard deviations from 10 random imaging locations in the same sample channel, and *** indicates p&lt;0.001 by the Student's t-test.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.00592.010">http://dx.doi.org/10.7554/eLife.00592.010</ext-link></p></caption><graphic xlink:href="elife-00592-fig7-v1"/></fig></p><p>To confirm that v-vesicle clustering induced by native α-Syn depends on lipid binding, we also measured the effect of the PD mutants on the number of v-/t-vesicle associations (<xref ref-type="fig" rid="fig7">Figure 7D</xref>). Only the A30P mutant increased the number of v-/t-vesicle associations. As mentioned above, the reduction of the number of v-/t-vesicle associations by native wildtype α-Syn is a consequence of the finite volume used during the incubation stage and the reduction of the number of free particles in the sample chamber by v-vesicle clustering. Thus, the numbers of v-vesicle clusters (<xref ref-type="fig" rid="fig7">Figure 7C</xref>) and v-/t-vesicle associations (<xref ref-type="fig" rid="fig7">Figure 7D</xref>) are anti-correlated.</p></sec><sec id="s2-4"><title>Native brain-purified α-Syn clusters v-vesicles</title><p>In order to test whether native brain-purified α-Syn has the same activity as native recombinant α-Syn in clustering v-vesicles, we purified native α-Syn from mouse brain without detergents or denaturants using multiple chromatography steps to a purity of &gt;90% (<xref ref-type="bibr" rid="bib8">Burré et al., In press</xref>). We found that the induction of v-vesicle clustering by native brain purified α-Syn was similar to that of native recombinant α-Syn (compare <xref ref-type="fig" rid="fig4 fig8">Figures 4A and 8</xref>), confirming that the observed clustering activity is not sensitive to the origin of α-Syn.<fig id="fig8" position="float"><object-id pub-id-type="doi">10.7554/eLife.00592.011</object-id><label>Figure 8.</label><caption><title>Native α-Syn purified from mouse brain induces v-vesicle clustering.</title><p>Error bars are standard deviations from 20 random imaging locations in the same sample channel. *** indicates p&lt;0.001 by the Student's t-test.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.00592.011">http://dx.doi.org/10.7554/eLife.00592.011</ext-link></p></caption><graphic xlink:href="elife-00592-fig8-v1"/></fig></p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The mechanism by which native α-Syn promotes SNARE-complex assembly in vitro and in vivo remains unknown (<xref ref-type="bibr" rid="bib13">Chandra et al., 2005</xref>; <xref ref-type="bibr" rid="bib7">Burré et al., 2010</xref>). Moreover, young αβγ-synuclein triple knockout mice showed no obvious phenotype, but developed neurological impairments during aging and revealed age-dependent impairments in SNARE-complex assembly (<xref ref-type="bibr" rid="bib7">Burré et al., 2010</xref>). Effects on neurotransmission were observed only upon prolonged trains of high-frequency stimulation (<xref ref-type="bibr" rid="bib1">Abeliovich et al., 2000</xref>; <xref ref-type="bibr" rid="bib10">Cabin et al., 2002</xref>) (however, see <xref ref-type="bibr" rid="bib12">Chandra et al., 2004</xref> for different results). Transgenic mice with overexpressed human α-Syn invariably exhibit signs of neurodegeneration, but impairment in synaptic vesicle exocytosis and a reduction in neurotransmitter release were observed only in some studies (<xref ref-type="bibr" rid="bib44">Nemani et al., 2010</xref>; <xref ref-type="bibr" rid="bib48">Scott et al., 2010</xref>) but not in another study (<xref ref-type="bibr" rid="bib7">Burré et al., 2010</xref>). Overexpression of α-Syn in the substantia nigra pars compacta of rodents using viral vectors also invariably leads to neurodegeneration (<xref ref-type="bibr" rid="bib6">Burré et al., 2012</xref>), and may cause an associated decrease in dopamine release (<xref ref-type="bibr" rid="bib27">Gaugler et al., 2012</xref>; <xref ref-type="bibr" rid="bib39">Lundblad et al., 2012</xref>).</p><p>We tested a possible function of native α-Syn using a reconstituted system consisting of v-vesicles that mimic synaptic vesicles, and t-vesicles that mimic the presynaptic plasma membrane. We found that native α-Syn did not affect the Ca<sup>2+</sup>-triggered fusion efficiency or fusion kinetics on a sub-second timescale (<xref ref-type="fig" rid="fig1">Figure 1</xref>). The lack of a noticeable effect of native α-Syn on Ca<sup>2+</sup>-triggered fusion in our synthetic system agrees well with extensive in vivo studies with synuclein double and triple knockout mice that showed little effect on synaptic strength (<xref ref-type="bibr" rid="bib12">Chandra et al., 2004</xref>; <xref ref-type="bibr" rid="bib7">Burré et al., 2010</xref>).</p><p>Although there was no effect on Ca<sup>2+</sup>-triggered fusion, we observed clustering of v-vesicles in the presence of native α-Syn (<xref ref-type="fig" rid="fig2 fig4 fig5">Figures 2, 4, and 5</xref>). Native α-Syn clustered both synaptobrevin-2 and synaptobrevin-2/synaptotagmin-1 v-vesicles (<xref ref-type="fig" rid="fig4">Figure 4D</xref>), and the clustering ability was dependent on the synaptobrevin-2 binding domain of α-Syn and the ability of α-Syn to bind to anionic lipids (<xref ref-type="fig" rid="fig4 fig7">Figures 4A,B and 7C</xref>). Furthermore, both recombinant and brain purified native α-Syn induced v-vesicle clustering (<xref ref-type="fig" rid="fig4 fig8">Figures 4 and 8</xref>).</p><p>The observed reduction in the number of associations between v-vesicles (single or multiple) and t-vesicles (<xref ref-type="fig" rid="fig2">Figure 2A</xref>) was correlated with an increase in the clustering of v-vesicles in the presence of α-Syn (<xref ref-type="fig" rid="fig4 fig5">Figures 4 and 5</xref>). This seemingly paradoxical result can be readily explained since the observed reduction in the number of v-/t-vesicle associations by native α-Syn is due to clustering of v-vesicles into larger particles, which effectively reduces the concentration of individual particles in the sample chamber (<xref ref-type="fig" rid="fig2">Figure 2C</xref>), and thus reduces the number of fluorescent spots.</p><p>The clustering activity of native α-Syn that we uncovered is very different from the effect of dopamine-induced large oligomers/aggregates of α-Syn (<xref ref-type="bibr" rid="bib15">Choi et al., 2013</xref>). We note that although both our v-/t-vesicle assay and the single-vesicle lipid mixing assay by (<xref ref-type="bibr" rid="bib15">Choi et al., 2013</xref>) revealed a reduction of the number of fluorescent (‘docked’) spots in v-/t-vesicle experiments, the underlying mechanism is different: while native α-Syn clusters v-vesicles and reduces the number of free particles in our v-/t-vesicle assay without interfering with SNARE interactions, large α-Syn oligomers interfere with SNARE complex formation and reduce docking in the lipid mixing assay of (<xref ref-type="bibr" rid="bib15">Choi et al., 2013</xref>).</p><p>It has been suggested that clusters of synaptic vesicles could act as a protein buffer (<xref ref-type="bibr" rid="bib19">Denker et al., 2011</xref>) to prevent the loss of accessory proteins involved in vesicle recycling. How could this be accomplished, and also result in an increase of SNARE complex assembly rate as observed by (<xref ref-type="bibr" rid="bib13">Chandra et al., 2005</xref>; <xref ref-type="bibr" rid="bib7">Burré et al., 2010</xref>)? We propose the following model (<xref ref-type="fig" rid="fig9">Figure 9</xref>): Under normal conditions, native α-Syn would contribute to clustering of synaptic vesicles at the active zone, and thereby assist with the formation of neuronal SNARE complexes by constraining additional synaptic vesicles to be close to the active zone. We found that the Parkinson's disease related A30P point mutant reduced the clustering activity of native α-Syn (<xref ref-type="fig" rid="fig7">Figure 7C</xref>), suggesting a possible loss-of-function phenotype for this mutant. Under certain other diseased conditions, excess amount of α-Syn could induce severe synaptic vesicle aggregation and thereby result in a reduced readily releasable synaptic vesicle pool, thus affecting neurotransmission.<fig id="fig9" position="float"><object-id pub-id-type="doi">10.7554/eLife.00592.012</object-id><label>Figure 9.</label><caption><title>Proposed model of native α-Syn function.</title><p>Native α-Syn binds at the same time to the synaptic vesicle membrane and synaptobrevin-2. Synaptic vesicle fusion with the presynaptic plasma membrane is mediated by the three neuronal SNARE proteins synaptobrevin-2 (on the synaptic vesicle membrane), SNAP-25 and syntaxin-1 (on the presynaptic plasma membrane), which form the synaptic SNARE-complex. Native α-Syn clusters synaptic vesicles depending on binding to synaptobrevin-2 and the vesicles themselves, which may result in a local increase of synaptic vesicles at the presynaptic plasma membrane, and a subsequent increase in SNARE-complex formation.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.00592.012">http://dx.doi.org/10.7554/eLife.00592.012</ext-link></p></caption><graphic xlink:href="elife-00592-fig9-v1"/></fig></p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Native recombinant α-Syn expression and purification</title><p>Full-length human α-Syn cDNA was cloned into modified pGEX-KG vectors (GE Healthcare, Uppsala, Sweden), containing an N-terminal TEV protease recognition site. Tag-free and myc-tagged constructs were prepared: The TEV protease cleavage site introduced one extra glycine residue at the N-terminus of the tag-free α-Syn sequence whereas the myc epitope-tagged α-Syn construct encoded the following extra N-terminal residues: GLE<underline>EQKLISEEDL</underline>GSGS (the myc epitope is underlined). All experiments except those shown in <xref ref-type="fig" rid="fig4">Figure 4B,D</xref> employed the tag-free α-Syn construct; we used the myc-tag construct for the experiments in <xref ref-type="fig" rid="fig4">Figure 4B</xref> since the C-terminal truncation mutant of α-Syn[1-95] could not be immuno-detected with our antibody. Mutant α-Syn constructs were generated by site-specific mutagenesis, according to the manufacturer's protocol (Stratagene; Agilent Technologies, Santa Clara, CA). All proteins were expressed as GST fusion proteins in bacteria (BL21 strain), essentially as described (<xref ref-type="bibr" rid="bib7">Burré et al., 2010</xref>). Bacteria were grown to OD 0.6 (measured at 600 nm), and protein expression was then induced with 0.05 mM isopropyl β-D-thiogalactoside (IPTG) for 6 hr at ambient temperature. Bacteria were harvested by centrifugation for 20 min at 4500 g, and pellets were resuspended in solubilization buffer (PBS, 0.5 mg/ml lysozyme, 1 mM PMSF, DNase, and an EDTA-free protease inhibitor cocktail; Roche Diagnostics Corporation, Indianapolis, IN). Cells were broken by sonication, and insoluble material was removed by centrifugation for 30 min at 20,000×<italic>g</italic><sub>av</sub> and 4°C. Proteins were affinity-purified using glutathione sepharose bead (GE Healthcare) incubation overnight at 4°C, followed by TEV protease (Invitrogen, Grand Island, NY) cleavage overnight at ambient temperature. His-tagged TEV protease was removed by incubation with Ni-NTA overnight at 4°C. The protein concentration was assessed using BCA method according to the manufacturer's protocol (Thermo Scientific, Rockford, IL). The protein sample was flash-frozen and stored at −80°C.</p></sec><sec id="s4-2"><title>Recombinant SNAREs, synaptotagmin-1 and complexin-1 expression and purification</title><p>All DNAs encode rat proteins, and were expressed and purified as described by (<xref ref-type="bibr" rid="bib34">Kyoung et al., 2011</xref>) with modifications (<xref ref-type="bibr" rid="bib21">Diao et al., 2012a</xref>). Briefly, his-tagged syntaxin-1A, synaptobrevin-2, SNAP-25A, and synaptotagmin-1 were expressed in <italic>E. coli</italic> and purified using a combination of Ni-NTA affinity (Qiagen, Hilden, Germany) and size exclusion chromatography on a Superdex 200 column (GE Healthcare). Synaptotagmin-1 was further purified using cation exchange chromatography on a Mono-S column (GE Healthcare). His-tags were removed from syntaxin-1A, synaptobrevin-2, and SNAP-25A with TEV protease, or from synaptotagmin-1 with PreScission protease (GE Healthcare). Wildtype complexin-1 was purified essentially as described (<xref ref-type="bibr" rid="bib21">Diao et al., 2012a</xref>) with modifications. Briefly, it was expressed as an N-terminal hexa-his tagged protein from pET28a (Novagen, EMD Chemicals, Gibbstown, NJ) in BL21 (DE3) at 30°C using an auto-induction system (<xref ref-type="bibr" rid="bib54">Studier, 2005</xref>). After binding to Ni-NTA beads, the protein was eluted by overnight cleavage with thrombin. Thrombin was then inactivated with 1 mM PMSF. The cleaved protein was subjected to size exclusion chromatography using a Superdex 200 10/300 column (GE Healthcare) and concentrated to 200 µM. 10% glycerol was added to all purified protein solutions. Complexin-1 and SNAP-25A were flash-frozen and stored as aliquots at −80°C, whereas synaptobrevin-2, synaptotagmin-1, and syntaxin-1A were used from freshly-made preparations.</p></sec><sec id="s4-3"><title>Native brain α-Syn purification</title><p>Mouse brains homogenized in phosphate-buffered saline (PBS) and protease inhibitors (Roche Diagnostics Corporation, Indianapolis, IN) were fractionated by ultracentrifugation (3 × 280,000×<italic>g</italic><sub>av</sub>). α-Syn was purified at 4°C by Q-Sepharose (GE Healthcare) anion exchange chromatography where α-Syn eluted at 0.3–0.5 M NaCl, 20 mM Tris–HCl pH 7.4, by phenyl-Sepharose (Sigma-Aldrich, St. Louis, MO) hydrophobic interaction chromatography where α-Syn was recovered in the flow-through in 1 M (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, and by gel filtration on a Superdex 200 10/300 GL column (AKTA; GE Healthcare) in PBS. Details can be found in <xref ref-type="bibr" rid="bib8">Burré et al. (2013)</xref>.</p></sec><sec id="s4-4"><title>Lipid binding assay</title><p>Preparation of vesicles and liposome flotation assay were performed as previously described (<xref ref-type="bibr" rid="bib7">Burré et al., 2010</xref>). Briefly, 1 mg brain phosphatidylcholine (PC; Avanti Polar Lipids, Alabaster, AL) or 0.7 mg PC and 0.3 mg brain phosphatidylserine (PCPS; Avanti Polar Lipids) in chloroform were dried in a glass vial under a nitrogen stream. Residual chloroform was removed by lyophilization for 2 hr. To obtain a solution of 1 mg/ml lipids, 1 ml PBS was added to each vial and vortexed well. Small unilamellar vesicles were formed by sonicating lipid solutions on ice (<xref ref-type="bibr" rid="bib3">Barenholz et al., 1977</xref>). For α-Syn binding to vesicles, 5 μg proteins were incubated with 100 µg vesicles for 2 hr at ambient temperature. Samples were then subjected to a liposome flotation assay as previously described (<xref ref-type="bibr" rid="bib7">Burré et al., 2010</xref>).</p></sec><sec id="s4-5"><title>Gel electrophoresis and protein quantitation</title><p>Quantitative immunoblotting experiments were performed with iodinated secondary antibodies as described previously (<xref ref-type="bibr" rid="bib47">Rosahl et al., 1995</xref>). Protein samples were separated by SDS-PAGE, and transferred onto nitrocellulose membranes. Blots were blocked in Tris-buffered saline (TBS) containing 0.1% Tween-20 (Sigma-Aldrich) and 3% fat-free milk for 30 min at ambient temperature. The blocked membrane was incubated overnight in blocking buffer containing primary antibody, followed by five washes. The washed membrane was incubated in blocking buffer containing either horseradish peroxidase (HRP)-conjugated secondary antibody (1:5000; MP Biomedicals, Santa Ana, CA) for 1 hr at ambient temperature, or <sup>125</sup>I-labeled secondary antibodies (1:1000; PerkinElmer, Santa Clara, CA). HRP immunoblots were developed using enhanced chemiluminescence (GE Healthcare). <sup>125</sup>I blots were exposed to a PhosphorImager screen (GE Healthcare) overnight and scanned using a Typhoon scanner (GE Healthcare), followed by quantitation with ImageQuant software (GE Healthcare).</p></sec><sec id="s4-6"><title>Primary antibodies</title><p>α-Syn (cl. 610786; BD Transduction, San Jose, CA), c-myc (cl. 9E10; Developmental Studies Hybridoma Bank, Iowa City, IA).</p></sec><sec id="s4-7"><title>Circular dichroism (CD) spectroscopy</title><p>CD spectra were collected with an Aviv model 202-01 spectrometer (Aviv Biomedical, Lakewood, NJ). Spectra are averages of eight replicates collected at 1-nm steps from 195 to 240 nm with a spectral bandwidth of 1 nm and a 1-s averaging time. The spectra of 1.4 μM α-Syn were acquired in pH 7.4, 18 mM NaCl, 4 mM HEPES, 4 μM EGTA, 0.2% β-mercaptoethanol with and without 960 µM lipids in protein-free vesicles that were formed with the same protocol (<xref ref-type="bibr" rid="bib35">Kyoung et al., 2012</xref>) used for the fusion and clustering experiments.</p></sec><sec id="s4-8"><title>Single vesicle-vesicle Ca<sup>2+</sup>-triggered fusion experiments</title><p>Our experimental setup was similar to that previously described (<xref ref-type="bibr" rid="bib21">Diao et al., 2012a</xref>; <xref ref-type="bibr" rid="bib35">Kyoung et al., 2012</xref>) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>), except that lipid dye was not used, and the time stamp of Ca<sup>2+</sup> arrival in the evanescent field was determined by the instance of the first content-mixing event (i.e., stepwise increase of content dye fluorescence intensity) among all docked vesicles.</p><p>T-vesicles (with reconstituted syntaxin-1A and SNAP-25A) and v-vesicles (with reconstituted synaptobrevin-2 and synaptotagmin-1) were prepared as previously described (<xref ref-type="bibr" rid="bib21">Diao et al., 2012a</xref>; <xref ref-type="bibr" rid="bib35">Kyoung et al., 2012</xref>). We showed previously that our particular vesicle preparation and protein reconstitution protocols (<xref ref-type="bibr" rid="bib35">Kyoung et al., 2012</xref>) produce homogeneous populations of vesicles with an average diameter of approximately 80 nm, and physiological protein concentrations (<xref ref-type="bibr" rid="bib34">Kyoung et al., 2011</xref>). The resulting t-vesicle solution was diluted 10× and immobilized on an imaging surface via biotin/neutravidin interactions under saturating conditions. Specifically, 100 µl of the diluted t-vesicle solution was injected into the sample chamber and incubated for 30 min, followed by a 200 μl vesicle buffer exchange (vesicle buffer is defined as 90 mM NaCl, 20 mM HEPES pH 7.4, 20 μM EGTA, 1% β-mercaptoethanol). V-vesicles (with reconstituted synaptobrevin-2 and synaptotagmin-1) containing self-quenched content dye (sulforhodamine B; Invitrogen) were prepared as previously described (<xref ref-type="bibr" rid="bib21">Diao et al., 2012a</xref>; <xref ref-type="bibr" rid="bib35">Kyoung et al., 2012</xref>). The v-vesicle solution was diluted 150× and added to the immobilized t-vesicle surface with 2 μM complexin-1 in presence or absence of 2 μM α-Syn. The presence of 2 μM α-Syn corresponds to a v-vesicle-lipid to α-Syn-protein ratio of 11:1, with the actual lipid to protein ratio being larger due to the presence of the saturated t-vesicle surface; at this condition, we did not observe destabilization of the v-SNARE vesicles by α-Syn since no leaking of content dyes from docked v-vesicles was observed. The system was incubated for 30 min, followed by buffer exchange (1 × 200 μl vesicle buffer for 6 s), removing unbound or weakly bound complexin and α-Syn. Then, 500 μM Ca<sup>2+</sup> buffer was injected into the sample chamber, and the fluorescence intensity of the content dye for each docked v-vesicle (but excluding few large fluorescent spots, see arrow in the lower right image of <xref ref-type="fig" rid="fig2">Figure 2A</xref>) was monitored with total internal reflection (TIR) wide-field microscopy (Nikon Instruments, Melville, NY) using an electron multiplying charge-coupled device (CCD) camera (iXon+ DV 897E; Andor Technology USA, South Windsor, CT). The smCamera program (written in C++) from Taekjip Ha's laboratory was used for data acquisition and analysis as described previously (<xref ref-type="bibr" rid="bib21">Diao et al., 2012a</xref>; <xref ref-type="bibr" rid="bib35">Kyoung et al., 2012</xref>). The number of v-/t-vesicle associations was calculated by counting the number of fluorescent spots prior to Ca<sup>2+</sup> injection, averaged over the specified number of images in the same sample channel. This simple averaging procedure was possible since the surface coverage was homogenous within the sample channel.</p><p>An instance of complete fusion was characterized by a stepwise increase in the content dye fluorescence intensity; this increase resulted from the approximately twofold dilution of the content dye upon fusion between a v- and a t-vesicle, and subsequent dequenching of the dye. For the histograms shown <xref ref-type="fig" rid="fig1">Figure 1B</xref>, the time stamp of Ca<sup>2+</sup> injection was defined as the instance of the first content-mixing event among all docked vesicles within a particular field of view. Histograms were combined from several fields of views by using these time stamps for post-synchronization. Histograms were self-normalized with respect to total number of fusion events, and cumulative distributions calculated. Histograms were fitted to bi-exponential decay functions using OriginPro 8.6 (OriginLab, Inc. Northampton, MA).</p></sec><sec id="s4-9"><title>Single-vesicle clustering experiments</title><p>For the clustering experiments the same v-vesicle preparation and protein reconstitution, and vesicle immobilization protocols were used as for the single vesicle-vesicle fusion experiments described in the previous section, except that lipid dyes were added. Specifically, a saturated layer of 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindodicarbocyanine perchlorate, DiIC18(5) (DiD) labeled synaptobrevin-2 containing v-vesicles was immobilized on an imaging surface via biotin/neutravidin interactions. The DiD-labeled synaptobrevin-2 v-vesicle solution (obtained by our reconstitution protocol; <xref ref-type="bibr" rid="bib21">Diao et al., 2012a</xref>; <xref ref-type="bibr" rid="bib35">Kyoung et al., 2012</xref>) was diluted 20×. 100 µl of the diluted vesicle solution was injected into the sample chamber and incubated for 30 min (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, left panel), followed by buffer exchange (1 × 200 μl vesicle buffer for 6 s). We confirmed that the vesicle-covered surfaces were saturated and produced a homogeneous distribution for each surface preparation with red laser excitation (633 nm) of the DiD-labeled immobilized vesicles (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, right image). As previously reported, more than 1000 vesicles could be immobilized with this method (<xref ref-type="bibr" rid="bib59">Yoon et al., 2008</xref>).</p><p>The immobilized v-vesicle surface was incubated for 30 min at the specified α-Syn concentration (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, middle panel); note that this is an additional step compared to the v-/t-vesicle fusion experiments described above. This step was followed by buffer exchange (1 × 200 μl vesicle buffer for 6 s), removing unbound or weakly bound α-Syn. Next, 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindodicarbocyanine perchlorate, DiIC18(5) (DiI)-labeled synaptobrevin-2 vesicles were also prepared with our reconstitution protocol (<xref ref-type="bibr" rid="bib21">Diao et al., 2012a</xref>; <xref ref-type="bibr" rid="bib35">Kyoung et al., 2012</xref>) and diluted 500×. 100 µl of diluted free-floating DiD-labeled v-vesicle solution was injected into the sample chamber (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, right panel); note that this v-vesicle solution did not contain α-Syn in order to prevent pre-clustering of this vesicle solution. After an incubation period of 120 min, unbound v-vesicles were removed by buffer exchange (2 × 200 μl vesicle buffer for ∼20 s).</p><p>Sample slides with multiple channels were monitored in a wide-field TIR fluorescence microscope, data were acquired with a CCD camera, and analyzed with the smCamera program, similar to the single vesicle-vesicle fusion experiments described above. A specified number of images were taken at random locations within each channel on the quartz slide. Details regarding software, slide assembly, and imaging protocols are described in reference (<xref ref-type="bibr" rid="bib22">Diao et al., 2012b</xref>). The number of v-/v-vesicle interactions (clustering) was determined by counting the number of fluorescent spots from emission of DiI upon excitation at 532 nm (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). The counts were averaged over the specified number of images at random locations in each sample channel. This simple averaging procedure was possible since the surface coverage was homogeneous. For each set of comparisons between different conditions and/or mutants (<xref ref-type="fig" rid="fig4 fig7 fig8">Figures 4A,B,D, 7C,D, and 8</xref>), the same protein preparations and surface preparations (quartz slide with immobilized vesicles) were used, and the conditions were run in separate channels on the same slide; although there was some variation in absolute numbers of counts (e.g., due to the use of tag-free vs tagged a-Syn constructs, <xref ref-type="fig" rid="fig4">Figure 4A</xref> vs <xref ref-type="fig" rid="fig4">Figure 4B,D</xref>), the relative differences were statistically similar for different protein preparations.</p></sec><sec id="s4-10"><title>Cryo-EM</title><p>Frozen-hydrated samples of synaptobrevin-2 v-vesicles in the presence of 20 μM α-Syn were prepared using the procedures for observation in cryo-EM as described previously (<xref ref-type="bibr" rid="bib34">Kyoung et al., 2011</xref>). Briefly, the synaptobrevin-2 v-vesicle solution obtained by our reconstitution protocol (<xref ref-type="bibr" rid="bib21">Diao et al., 2012a</xref>; <xref ref-type="bibr" rid="bib35">Kyoung et al., 2012</xref>) was diluted 5× in the presence of 20 μM α-Syn (resulting in v-vesicle-lipid to α-Syn-protein ratio of 33:1) and then incubated on a glow-discharged lacey Form var/carbon 300 mesh copper grid (Ted Palla, Redding, CA, USA), followed by blotting and plunging into liquid ethane. Thus, the concentration of the vesicles used in the cryo-EM experiments was 100-fold higher than in the single vesicle-vesicle clustering experiments. The frozen-hydrated specimen was subsequently observed at liquid nitrogen temperature using a CM200F electron microscope (FEI, Hillsboro, OR, USA) operating at 200 kV, under low dose conditions. Images were collected at a 50,000× magnification and 1.5 µm under-focus on a 2k × 2k UltraScan 1000 camera (Gatan, Inc., Pleasanton, CA).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank Patricia Grob and Eva Nogales for cryo-electron microscopy, Minglei Zhao for stimulating discussions, Mark Padolina and Richard Pfuetzner for performing protein purifications, and Steven Chu for an exciting long-term collaboration that lead to the single-vesicle fusion system.</p></ack><sec sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="conflict" id="conf1"><p>ATB, Reviewing editor, <italic>eLife</italic>.</p></fn><fn fn-type="conflict" id="conf2"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>JD, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con2"><p>JB, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con3"><p>SV, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con4"><p>DJC, Analysis and interpretation of data, Drafting or revising the article, Contributed unpublished essential data or reagents</p></fn><fn fn-type="con" id="con5"><p>MS, Acquisition of data, Analysis and interpretation of data, Contributed unpublished essential data or reagents</p></fn><fn fn-type="con" id="con6"><p>MK, Analysis and interpretation of data, Contributed unpublished essential data or reagents</p></fn><fn fn-type="con" id="con7"><p>TCS, Conception and design, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con8"><p>ATB, Conception and design, Analysis and interpretation of data, Drafting or revising the article</p></fn></fn-group></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abeliovich</surname><given-names>A</given-names></name><name><surname>Schmitz</surname><given-names>Y</given-names></name><name><surname>Farinas</surname><given-names>I</given-names></name><name><surname>Choi-Lundberg</surname><given-names>D</given-names></name><name><surname>Ho</surname><given-names>WH</given-names></name><name><surname>Castillo</surname><given-names>PE</given-names></name><etal/></person-group><year>2000</year><article-title>Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system</article-title><source>Neuron</source><volume>25</volume><fpage>239</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(00)80886-7</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anwar</surname><given-names>S</given-names></name><name><surname>Peters</surname><given-names>O</given-names></name><name><surname>Millership</surname><given-names>S</given-names></name><name><surname>Ninkina</surname><given-names>N</given-names></name><name><surname>Doig</surname><given-names>N</given-names></name><name><surname>Connor-Robson</surname><given-names>N</given-names></name><etal/></person-group><year>2011</year><article-title>Functional alterations to the nigrostriatal system in mice lacking all three members of the synuclein family</article-title><source>J Neurosci</source><volume>31</volume><fpage>7264</fpage><lpage>7274</lpage><pub-id pub-id-type="doi">10.1523/Jneurosci.6194-10.2011</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barenholz</surname><given-names>Y</given-names></name><name><surname>Gibbes</surname><given-names>D</given-names></name><name><surname>Litman</surname><given-names>BJ</given-names></name><name><surname>Goll</surname><given-names>J</given-names></name><name><surname>Thompson</surname><given-names>TE</given-names></name><name><surname>Carlson</surname><given-names>FD</given-names></name></person-group><year>1977</year><article-title>Simple method for preparation of homogeneous phospholipid vesicles</article-title><source>Biochemistry</source><volume>16</volume><fpage>2806</fpage><lpage>2810</lpage><pub-id pub-id-type="doi">10.1021/Bi00631a035</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bodner</surname><given-names>CR</given-names></name><name><surname>Dobson</surname><given-names>CM</given-names></name><name><surname>Bax</surname><given-names>A</given-names></name></person-group><year>2009</year><article-title>Multiple tight phospholipid-binding modes of alpha-synuclein revealed by solution NMR spectroscopy</article-title><source>J Mol Biol</source><volume>390</volume><fpage>775</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2009.05.066</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bucciantini</surname><given-names>M</given-names></name><name><surname>Giannoni</surname><given-names>E</given-names></name><name><surname>Chiti</surname><given-names>F</given-names></name><name><surname>Baroni</surname><given-names>F</given-names></name><name><surname>Formigli</surname><given-names>L</given-names></name><name><surname>Zurdo</surname><given-names>J</given-names></name><etal/></person-group><year>2002</year><article-title>Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases</article-title><source>Nature</source><volume>416</volume><fpage>507</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1038/416507a</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burré</surname><given-names>J</given-names></name><name><surname>Sharma</surname><given-names>M</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name></person-group><year>2012</year><article-title>Systematic mutagenesis of alpha-synuclein reveals distinct sequence requirements for physiological and pathological activities</article-title><source>J Neurosci</source><volume>32</volume><fpage>15227</fpage><lpage>15242</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3545-12.2012</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burré</surname><given-names>J</given-names></name><name><surname>Sharma</surname><given-names>M</given-names></name><name><surname>Tsetsenis</surname><given-names>T</given-names></name><name><surname>Buchman</surname><given-names>V</given-names></name><name><surname>Etherton</surname><given-names>MR</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name></person-group><year>2010</year><article-title>Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro</article-title><source>Science</source><volume>329</volume><fpage>1663</fpage><lpage>1667</lpage><pub-id pub-id-type="doi">10.1126/Science.1195227</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burré</surname><given-names>J</given-names></name><name><surname>Vivona</surname><given-names>S</given-names></name><name><surname>Diao</surname><given-names>J</given-names></name><name><surname>Sharma</surname><given-names>M</given-names></name><name><surname>Brunger</surname><given-names>AT</given-names></name><name><surname>Südhof</surname><given-names>T</given-names></name></person-group><comment>In press</comment><article-title>α-Synuclein in brain cytosol is predominantly monomeric but prone to aggregation</article-title><source>Nature</source><pub-id pub-id-type="doi">10.1038/nature12125</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bussell</surname><given-names>R</given-names><suffix>Jnr</suffix></name><name><surname>Eliezer</surname><given-names>D</given-names></name></person-group><year>2003</year><article-title>A structural and functional role for 11-mer repeats in alpha-synuclein and other exchangeable lipid binding proteins</article-title><source>J Mol Biol</source><volume>329</volume><fpage>763</fpage><lpage>778</lpage><pub-id pub-id-type="doi">10.1016/S0022-2836(03)00520-5</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabin</surname><given-names>DE</given-names></name><name><surname>Shimazu</surname><given-names>K</given-names></name><name><surname>Murphy</surname><given-names>D</given-names></name><name><surname>Cole</surname><given-names>NB</given-names></name><name><surname>Gottschalk</surname><given-names>W</given-names></name><name><surname>McIlwain</surname><given-names>KL</given-names></name><etal/></person-group><year>2002</year><article-title>Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein</article-title><source>J Neurosci</source><volume>22</volume><fpage>8797</fpage><lpage>8807</lpage></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandra</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Rizo</surname><given-names>J</given-names></name><name><surname>Jahn</surname><given-names>R</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name></person-group><year>2003</year><article-title>A broken alpha-helix in folded alpha-Synuclein</article-title><source>J Biol Chem</source><volume>278</volume><fpage>15313</fpage><lpage>15318</lpage><pub-id pub-id-type="doi">10.1074/jbc.M213128200</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandra</surname><given-names>S</given-names></name><name><surname>Fornai</surname><given-names>F</given-names></name><name><surname>Kwon</surname><given-names>HB</given-names></name><name><surname>Yazdani</surname><given-names>U</given-names></name><name><surname>Atasoy</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>XR</given-names></name><etal/></person-group><year>2004</year><article-title>Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions</article-title><source>Proc Natl Acad Sci USA</source><volume>101</volume><fpage>14966</fpage><lpage>14971</lpage><pub-id pub-id-type="doi">10.1073/Pnas.0406283101</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandra</surname><given-names>S</given-names></name><name><surname>Gallardo</surname><given-names>G</given-names></name><name><surname>Fernandez-Chacon</surname><given-names>R</given-names></name><name><surname>Schluter</surname><given-names>OM</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name></person-group><year>2005</year><article-title>Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration</article-title><source>Cell</source><volume>123</volume><fpage>383</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.09.028</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chartier-Harlin</surname><given-names>MC</given-names></name><name><surname>Kachergus</surname><given-names>J</given-names></name><name><surname>Roumier</surname><given-names>C</given-names></name><name><surname>Mouroux</surname><given-names>V</given-names></name><name><surname>Douay</surname><given-names>X</given-names></name><name><surname>Lincoln</surname><given-names>S</given-names></name><etal/></person-group><year>2004</year><article-title>Alpha-synuclein locus duplication as a cause of familial Parkinson's disease</article-title><source>Lancet</source><volume>364</volume><fpage>1167</fpage><lpage>1169</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(04)17103-1</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>BK</given-names></name><name><surname>Choi</surname><given-names>MG</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Lai</surname><given-names>Y</given-names></name><name><surname>Kweon</surname><given-names>DH</given-names></name><etal/></person-group><year>2013</year><article-title>Large alpha-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking</article-title><source>Proc Natl Acad Sci USA</source><volume>110</volume><fpage>4087</fpage><lpage>4092</lpage><pub-id pub-id-type="doi">10.1073/pnas.1218424110</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clayton</surname><given-names>DF</given-names></name><name><surname>George</surname><given-names>JM</given-names></name></person-group><year>1998</year><article-title>The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease</article-title><source>Trends Neurosci</source><volume>21</volume><fpage>249</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1016/S0166-2236(97)01213-7</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conway</surname><given-names>KA</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name><name><surname>Rochet</surname><given-names>JC</given-names></name><name><surname>Ding</surname><given-names>TT</given-names></name><name><surname>Harper</surname><given-names>JD</given-names></name><name><surname>Williamson</surname><given-names>RE</given-names></name><etal/></person-group><year>2000</year><article-title>Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants</article-title><source>Ann NY Acad Sci</source><volume>920</volume><fpage>42</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.2000.tb06903.x</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>WS</given-names></name><name><surname>Jonas</surname><given-names>A</given-names></name><name><surname>Clayton</surname><given-names>DF</given-names></name><name><surname>George</surname><given-names>JM</given-names></name></person-group><year>1998</year><article-title>Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes</article-title><source>J Biol Chem</source><volume>273</volume><fpage>9443</fpage><lpage>9449</lpage><pub-id pub-id-type="doi">10.1074/jbc.273.16.9443</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denker</surname><given-names>A</given-names></name><name><surname>Bethani</surname><given-names>I</given-names></name><name><surname>Krohnert</surname><given-names>K</given-names></name><name><surname>Korber</surname><given-names>C</given-names></name><name><surname>Horstmann</surname><given-names>H</given-names></name><name><surname>Wilhelm</surname><given-names>BG</given-names></name><etal/></person-group><year>2011</year><article-title>A small pool of vesicles maintains synaptic activity in vivo</article-title><source>Proc Natl Acad Sci USA</source><volume>108</volume><fpage>17177</fpage><lpage>17182</lpage><pub-id pub-id-type="doi">10.1073/Pnas.1112688108</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devine</surname><given-names>MJ</given-names></name><name><surname>Gwinn</surname><given-names>K</given-names></name><name><surname>Singleton</surname><given-names>A</given-names></name><name><surname>Hardy</surname><given-names>J</given-names></name></person-group><year>2011</year><article-title>Parkinson's disease and alpha-synuclein expression</article-title><source>Mov Disord</source><volume>26</volume><fpage>2160</fpage><lpage>2168</lpage><pub-id pub-id-type="doi">10.1002/mds.23948</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diao</surname><given-names>J</given-names></name><name><surname>Grob</surname><given-names>P</given-names></name><name><surname>Cipriano</surname><given-names>DJ</given-names></name><name><surname>Kyoung</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Shah</surname><given-names>S</given-names></name><etal/></person-group><year>2012a</year><article-title>Synaptic proteins promote calcium-triggered fast transition from point contact to full fusion</article-title><source>eLife</source><volume>1</volume><fpage>e00109</fpage><pub-id pub-id-type="doi">10.7554/eLife.00109</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diao</surname><given-names>J</given-names></name><name><surname>Ishitsuka</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Joo</surname><given-names>C</given-names></name><name><surname>Su</surname><given-names>ZL</given-names></name><name><surname>Syed</surname><given-names>S</given-names></name><etal/></person-group><year>2012b</year><article-title>A single vesicle-vesicle fusion assay for in vitro studies of SNAREs and accessory proteins</article-title><source>Nat Protoc</source><volume>7</volume><fpage>921</fpage><lpage>934</lpage><pub-id pub-id-type="doi">10.1038/Nprot.2012.020</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eliezer</surname><given-names>D</given-names></name><name><surname>Kutluay</surname><given-names>E</given-names></name><name><surname>Bussell</surname><given-names>R</given-names><suffix>Jnr</suffix></name><name><surname>Browne</surname><given-names>G</given-names></name></person-group><year>2001</year><article-title>Conformational properties of alpha-synuclein in its free and lipid-associated states</article-title><source>J Mol Biol</source><volume>307</volume><fpage>1061</fpage><lpage>1073</lpage><pub-id pub-id-type="doi">10.1006/jmbi.2001.4538</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fauvet</surname><given-names>B</given-names></name><name><surname>Mbefo</surname><given-names>MK</given-names></name><name><surname>Fares</surname><given-names>MB</given-names></name><name><surname>Desobry</surname><given-names>C</given-names></name><name><surname>Michael</surname><given-names>S</given-names></name><name><surname>Ardah</surname><given-names>MT</given-names></name><etal/></person-group><year>2012</year><article-title>α-Synuclein in central nervous system and from erythrocytes, mammalian cells, and <italic>Escherichia coli</italic> exists predominantly as disordered monomer</article-title><source>J Biol Chem</source><volume>287</volume><fpage>15345</fpage><lpage>15364</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.318949</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreon</surname><given-names>AC</given-names></name><name><surname>Gambin</surname><given-names>Y</given-names></name><name><surname>Lemke</surname><given-names>EA</given-names></name><name><surname>Deniz</surname><given-names>AA</given-names></name></person-group><year>2009</year><article-title>Interplay of alpha-synuclein binding and conformational switching probed by single-molecule fluorescence</article-title><source>Proc Natl Acad Sci USA</source><volume>106</volume><fpage>5645</fpage><lpage>5650</lpage><pub-id pub-id-type="doi">10.1073/pnas.0809232106</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Reitbock</surname><given-names>P</given-names></name><name><surname>Anichtchik</surname><given-names>O</given-names></name><name><surname>Bellucci</surname><given-names>A</given-names></name><name><surname>Iovino</surname><given-names>M</given-names></name><name><surname>Ballini</surname><given-names>C</given-names></name><name><surname>Fineberg</surname><given-names>E</given-names></name><etal/></person-group><year>2010</year><article-title>SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease</article-title><source>Brain</source><volume>133</volume><fpage>2032</fpage><lpage>2044</lpage><pub-id pub-id-type="doi">10.1093/brain/awq132</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaugler</surname><given-names>MN</given-names></name><name><surname>Genc</surname><given-names>O</given-names></name><name><surname>Bobela</surname><given-names>W</given-names></name><name><surname>Mohanna</surname><given-names>S</given-names></name><name><surname>Ardah</surname><given-names>MT</given-names></name><name><surname>El-Agnaf</surname><given-names>OM</given-names></name><etal/></person-group><year>2012</year><article-title>Nigrostriatal overabundance of alpha-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity</article-title><source>Acta Neuropathol</source><volume>123</volume><fpage>653</fpage><lpage>669</lpage><pub-id pub-id-type="doi">10.1007/s00401-012-0963-y</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldberg</surname><given-names>MS</given-names></name><name><surname>Lansbury</surname><given-names>PT</given-names><suffix>Jnr</suffix></name></person-group><year>2000</year><article-title>Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease?</article-title><source>Nat Cell Biol</source><volume>2</volume><fpage>E115</fpage><lpage>E119</lpage><pub-id pub-id-type="doi">10.1038/35017124</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardy</surname><given-names>J</given-names></name><name><surname>Gwinn-Hardy</surname><given-names>K</given-names></name></person-group><year>1998</year><article-title>Genetic classification of primary neurodegenerative disease</article-title><source>Science</source><volume>282</volume><fpage>1075</fpage><lpage>1079</lpage><pub-id pub-id-type="doi">10.1126/Science.282.5391.1075</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jao</surname><given-names>CC</given-names></name><name><surname>Hegde</surname><given-names>BG</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Haworth</surname><given-names>IS</given-names></name><name><surname>Langen</surname><given-names>R</given-names></name></person-group><year>2008</year><article-title>Structure of membrane-bound alpha-synuclein from site-directed spin labeling and computational refinement</article-title><source>Proc Natl Acad Sci USA</source><volume>105</volume><fpage>19666</fpage><lpage>19671</lpage><pub-id pub-id-type="doi">10.1073/pnas.0807826105</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>PH</given-names></name><name><surname>Nielsen</surname><given-names>MS</given-names></name><name><surname>Jakes</surname><given-names>R</given-names></name><name><surname>Dotti</surname><given-names>CG</given-names></name><name><surname>Goedert</surname><given-names>M</given-names></name></person-group><year>1998</year><article-title>Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation</article-title><source>J Biol Chem</source><volume>273</volume><fpage>26292</fpage><lpage>26294</lpage><pub-id pub-id-type="doi">10.1074/jbc.273.41.26292</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jo</surname><given-names>E</given-names></name><name><surname>McLaurin</surname><given-names>J</given-names></name><name><surname>Yip</surname><given-names>CM</given-names></name><name><surname>St George-Hyslop</surname><given-names>P</given-names></name><name><surname>Fraser</surname><given-names>PE</given-names></name></person-group><year>2000</year><article-title>alpha-Synuclein membrane interactions and lipid specificity</article-title><source>J Biol Chem</source><volume>275</volume><fpage>34328</fpage><lpage>34334</lpage><pub-id pub-id-type="doi">10.1074/jbc.M004345200</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kruger</surname><given-names>R</given-names></name><name><surname>Kuhn</surname><given-names>W</given-names></name><name><surname>Muller</surname><given-names>T</given-names></name><name><surname>Woitalla</surname><given-names>D</given-names></name><name><surname>Graeber</surname><given-names>M</given-names></name><name><surname>Kosel</surname><given-names>S</given-names></name><etal/></person-group><year>1998</year><article-title>Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease</article-title><source>Nat Genet</source><volume>18</volume><fpage>106</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1038/ng0298-106</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kyoung</surname><given-names>M</given-names></name><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>YX</given-names></name><name><surname>Diao</surname><given-names>JJ</given-names></name><name><surname>Vrljic</surname><given-names>M</given-names></name><name><surname>Grob</surname><given-names>P</given-names></name><etal/></person-group><year>2011</year><article-title>In vitro system capable of differentiating fast Ca(2+)-triggered content mixing from lipid exchange for mechanistic studies of neurotransmitter release</article-title><source>Proc Natl Acad Sci USA</source><volume>108</volume><fpage>E304</fpage><lpage>E313</lpage><pub-id pub-id-type="doi">10.1073/Pnas.1107900108</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kyoung</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Diao</surname><given-names>J</given-names></name><name><surname>Chu</surname><given-names>S</given-names></name><name><surname>Brunger</surname><given-names>AT</given-names></name></person-group><year>2012</year><article-title>Studying calcium-triggered vesicle fusion in a single vesicle-vesicle content and lipid-mixing system</article-title><source>Nat Protoc</source><volume>8</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1038/nprot.2012.134</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsen</surname><given-names>KE</given-names></name><name><surname>Schmitz</surname><given-names>Y</given-names></name><name><surname>Troyer</surname><given-names>MD</given-names></name><name><surname>Mosharov</surname><given-names>E</given-names></name><name><surname>Dietrich</surname><given-names>P</given-names></name><name><surname>Quazi</surname><given-names>AZ</given-names></name><etal/></person-group><year>2006</year><article-title>Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis</article-title><source>J Neurosci</source><volume>26</volume><fpage>11915</fpage><lpage>11922</lpage><pub-id pub-id-type="doi">10.1523/Jneurosci.3821-06.2006</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>SM</given-names></name><name><surname>Ninan</surname><given-names>I</given-names></name><name><surname>Antonova</surname><given-names>I</given-names></name><name><surname>Battaglia</surname><given-names>F</given-names></name><name><surname>Trinchese</surname><given-names>F</given-names></name><name><surname>Narasanna</surname><given-names>A</given-names></name><etal/></person-group><year>2004</year><article-title>alpha-Synuclein produces a long-lasting increase in neurotransmitter release</article-title><source>EMBO J</source><volume>23</volume><fpage>4506</fpage><lpage>4516</lpage><pub-id pub-id-type="doi">10.1038/Sj.Emboj.7600451</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lokappa</surname><given-names>SB</given-names></name><name><surname>Ulmer</surname><given-names>TS</given-names></name></person-group><year>2011</year><article-title>Alpha-synuclein populates both elongated and broken helix states on small unilamellar vesicles</article-title><source>J Biol Chem</source><volume>286</volume><fpage>21450</fpage><lpage>21457</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.224055</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lundblad</surname><given-names>M</given-names></name><name><surname>Decressac</surname><given-names>M</given-names></name><name><surname>Mattsson</surname><given-names>B</given-names></name><name><surname>Bjorklund</surname><given-names>A</given-names></name></person-group><year>2012</year><article-title>Impaired neurotransmission caused by overexpression of alpha-synuclein in nigral dopamine neurons</article-title><source>Proc Natl Acad Sci USA</source><volume>109</volume><fpage>3213</fpage><lpage>3219</lpage><pub-id pub-id-type="doi">10.1073/pnas.1200575109</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maltsev</surname><given-names>AS</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Levine</surname><given-names>RL</given-names></name><name><surname>Bax</surname><given-names>A</given-names></name></person-group><year>2013</year><article-title>Site-specific interaction between alpha-synuclein and membranes probed by NMR-observed methionine oxidation rates</article-title><source>J Am Chem Soc</source><volume>135</volume><fpage>2943</fpage><lpage>2946</lpage><pub-id pub-id-type="doi">10.1021/ja312415q</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maltsev</surname><given-names>AS</given-names></name><name><surname>Ying</surname><given-names>J</given-names></name><name><surname>Bax</surname><given-names>A</given-names></name></person-group><year>2012</year><article-title>Impact of N-terminal acetylation of alpha-synuclein on its random coil and lipid binding properties</article-title><source>Biochemistry</source><volume>51</volume><fpage>5004</fpage><lpage>5013</lpage><pub-id pub-id-type="doi">10.1021/bi300642h</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maroteaux</surname><given-names>L</given-names></name><name><surname>Campanelli</surname><given-names>JT</given-names></name><name><surname>Scheller</surname><given-names>RH</given-names></name></person-group><year>1988</year><article-title>Synuclein—a neuron-specific protein localized to the nucleus and presynaptic nerve-terminal</article-title><source>J Neurosci</source><volume>8</volume><fpage>2804</fpage><lpage>2815</lpage></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>I</given-names></name><name><surname>Dawson</surname><given-names>VL</given-names></name><name><surname>Dawson</surname><given-names>TM</given-names></name></person-group><year>2011</year><article-title>Recent advances in the genetics of Parkinson's disease</article-title><source>Annu Rev Genomics Hum Genet</source><volume>12</volume><fpage>301</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1146/annurev-genom-082410-101440</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nemani</surname><given-names>VM</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Berge</surname><given-names>V</given-names></name><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Onoa</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>MK</given-names></name><etal/></person-group><year>2010</year><article-title>Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis</article-title><source>Neuron</source><volume>65</volume><fpage>66</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2009.12.023</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polymeropoulos</surname><given-names>MH</given-names></name><name><surname>Lavedan</surname><given-names>C</given-names></name><name><surname>Leroy</surname><given-names>E</given-names></name><name><surname>Ide</surname><given-names>SE</given-names></name><name><surname>Dehejia</surname><given-names>A</given-names></name><name><surname>Dutra</surname><given-names>A</given-names></name><etal/></person-group><year>1997</year><article-title>Mutation in the alpha-synuclein gene identified in families with Parkinson's disease</article-title><source>Science</source><volume>276</volume><fpage>2045</fpage><lpage>2047</lpage><pub-id pub-id-type="doi">10.1126/science.276.5321.2045</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhoades</surname><given-names>E</given-names></name><name><surname>Ramlall</surname><given-names>TF</given-names></name><name><surname>Webb</surname><given-names>WW</given-names></name><name><surname>Eliezer</surname><given-names>D</given-names></name></person-group><year>2006</year><article-title>Quantification of alpha-synuclein binding to lipid vesicles using fluorescence correlation spectroscopy</article-title><source>Biophys J</source><volume>90</volume><fpage>4692</fpage><lpage>4700</lpage><pub-id pub-id-type="doi">10.1529/biophysj.105.079251</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosahl</surname><given-names>TW</given-names></name><name><surname>Spillane</surname><given-names>D</given-names></name><name><surname>Missler</surname><given-names>M</given-names></name><name><surname>Herz</surname><given-names>J</given-names></name><name><surname>Selig</surname><given-names>DK</given-names></name><name><surname>Wolff</surname><given-names>JR</given-names></name><etal/></person-group><year>1995</year><article-title>Essential functions of synapsins I and II in synaptic vesicle regulation</article-title><source>Nature</source><volume>375</volume><fpage>488</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1038/375488a0</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>DA</given-names></name><name><surname>Tabarean</surname><given-names>I</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Cartier</surname><given-names>A</given-names></name><name><surname>Masliah</surname><given-names>E</given-names></name><name><surname>Roy</surname><given-names>S</given-names></name></person-group><year>2010</year><article-title>A pathologic cascade leading to synaptic dysfunction in alpha-synuclein-induced neurodegeneration</article-title><source>J Neurosci</source><volume>30</volume><fpage>8083</fpage><lpage>8095</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1091-10.2010</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Senior</surname><given-names>SL</given-names></name><name><surname>Ninkina</surname><given-names>N</given-names></name><name><surname>Deacon</surname><given-names>R</given-names></name><name><surname>Bannerman</surname><given-names>D</given-names></name><name><surname>Buchman</surname><given-names>VL</given-names></name><name><surname>Cragg</surname><given-names>SJ</given-names></name><etal/></person-group><year>2008</year><article-title>Increased striatal dopamine release and hyperdopaminergic-like behaviour in mice lacking both alpha-synuclein and gamma-synuclein</article-title><source>Eur J Neurosci</source><volume>27</volume><fpage>947</fpage><lpage>957</lpage><pub-id pub-id-type="doi">10.1111/J.1460-9568.2008.06055.X</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serpell</surname><given-names>LC</given-names></name><name><surname>Berriman</surname><given-names>J</given-names></name><name><surname>Jakes</surname><given-names>R</given-names></name><name><surname>Goedert</surname><given-names>M</given-names></name><name><surname>Crowther</surname><given-names>RA</given-names></name></person-group><year>2000</year><article-title>Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation</article-title><source>Proc Natl Acad Sci USA</source><volume>97</volume><fpage>4897</fpage><lpage>4902</lpage><pub-id pub-id-type="doi">10.1073/pnas.97.9.4897</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singleton</surname><given-names>AB</given-names></name><name><surname>Farrer</surname><given-names>M</given-names></name><name><surname>Johnson</surname><given-names>J</given-names></name><name><surname>Singleton</surname><given-names>A</given-names></name><name><surname>Hague</surname><given-names>S</given-names></name><name><surname>Kachergus</surname><given-names>J</given-names></name><etal/></person-group><year>2003</year><article-title>alpha-Synuclein locus triplication causes Parkinson's disease</article-title><source>Science</source><volume>302</volume><fpage>841</fpage><pub-id pub-id-type="doi">10.1126/science.1090278</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spillantini</surname><given-names>MG</given-names></name><name><surname>Crowther</surname><given-names>RA</given-names></name><name><surname>Jakes</surname><given-names>R</given-names></name><name><surname>Hasegawa</surname><given-names>M</given-names></name><name><surname>Goedert</surname><given-names>M</given-names></name></person-group><year>1998</year><article-title>alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies</article-title><source>Proc Natl Acad Sci USA</source><volume>95</volume><fpage>6469</fpage><lpage>6473</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.11.6469</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spillantini</surname><given-names>MG</given-names></name><name><surname>Schmidt</surname><given-names>ML</given-names></name><name><surname>Lee</surname><given-names>VMY</given-names></name><name><surname>Trojanowski</surname><given-names>JQ</given-names></name><name><surname>Jakes</surname><given-names>R</given-names></name><name><surname>Goedert</surname><given-names>M</given-names></name></person-group><year>1997</year><article-title>alpha-Synuclein in Lewy bodies</article-title><source>Nature</source><volume>388</volume><fpage>839</fpage><lpage>840</lpage><pub-id pub-id-type="doi">10.1038/42166</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Studier</surname><given-names>FW</given-names></name></person-group><year>2005</year><article-title>Protein production by auto-induction in high density shaking cultures</article-title><source>Protein Expr Purif</source><volume>41</volume><fpage>207</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1016/j.pep.2005.01.016</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulmer</surname><given-names>TS</given-names></name><name><surname>Bax</surname><given-names>A</given-names></name><name><surname>Cole</surname><given-names>NB</given-names></name><name><surname>Nussbaum</surname><given-names>RL</given-names></name></person-group><year>2005</year><article-title>Structure and dynamics of micelle-bound human alpha-synuclein</article-title><source>J Biol Chem</source><volume>280</volume><fpage>9595</fpage><lpage>9603</lpage><pub-id pub-id-type="doi">10.1074/jbc.M411805200</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unger</surname><given-names>EL</given-names></name><name><surname>Eve</surname><given-names>DJ</given-names></name><name><surname>Perez</surname><given-names>XA</given-names></name><name><surname>Reichenbach</surname><given-names>DK</given-names></name><name><surname>Xu</surname><given-names>YQ</given-names></name><name><surname>Lee</surname><given-names>MK</given-names></name><etal/></person-group><year>2006</year><article-title>Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human alpha-synuclein in mice</article-title><source>Neurobiol Dis</source><volume>21</volume><fpage>431</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2005.08.005</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Perovic</surname><given-names>I</given-names></name><name><surname>Chittuluru</surname><given-names>J</given-names></name><name><surname>Kaganovich</surname><given-names>A</given-names></name><name><surname>Nguyen</surname><given-names>LT</given-names></name><name><surname>Liao</surname><given-names>J</given-names></name><etal/></person-group><year>2011</year><article-title>A soluble alpha-synuclein construct forms a dynamic tetramer</article-title><source>Proc Natl Acad Sci USA</source><volume>108</volume><fpage>17797</fpage><lpage>17802</lpage><pub-id pub-id-type="doi">10.1073/pnas.1113260108</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yavich</surname><given-names>L</given-names></name><name><surname>Tanila</surname><given-names>H</given-names></name><name><surname>Vepsalainen</surname><given-names>S</given-names></name><name><surname>Jakala</surname><given-names>P</given-names></name></person-group><year>2004</year><article-title>Role of alpha-synuclein in presynaptic dopamine recruitment</article-title><source>J Neurosci</source><volume>24</volume><fpage>11165</fpage><lpage>11170</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2559-04.2004</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>TY</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Diao</surname><given-names>JJ</given-names></name><name><surname>Lee</surname><given-names>SM</given-names></name><name><surname>Ha</surname><given-names>T</given-names></name><name><surname>Shin</surname><given-names>YK</given-names></name></person-group><year>2008</year><article-title>Complexin and Ca(2+) stimulate SNARE-mediated membrane fusion</article-title><source>Nat Struct Mol Biol</source><volume>15</volume><fpage>707</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1038/Nsmb.1446</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarranz</surname><given-names>JJ</given-names></name><name><surname>Alegre</surname><given-names>J</given-names></name><name><surname>Gomez-Esteban</surname><given-names>JC</given-names></name><name><surname>Lezcano</surname><given-names>E</given-names></name><name><surname>Ros</surname><given-names>R</given-names></name><name><surname>Ampuero</surname><given-names>I</given-names></name><etal/></person-group><year>2004</year><article-title>The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia</article-title><source>Ann Neurol</source><volume>55</volume><fpage>164</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1002/ana.10795</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>M</given-names></name><name><surname>Cascio</surname><given-names>D</given-names></name><name><surname>Sawaya</surname><given-names>MR</given-names></name><name><surname>Eisenberg</surname><given-names>D</given-names></name></person-group><year>2011</year><article-title>Structures of segments of alpha-synuclein fused to maltose-binding protein suggest intermediate states during amyloid formation</article-title><source>Protein Sci</source><volume>20</volume><fpage>996</fpage><lpage>1004</lpage><pub-id pub-id-type="doi">10.1002/pro.630</pub-id></element-citation></ref></ref-list></back><sub-article article-type="article-commentary" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.00592.013</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Jahn</surname><given-names>Reinhard</given-names></name><role>Reviewing editor</role><aff><institution>Max Planck Institute for Biophysical Chemistry</institution>, <country>Germany</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see <ext-link ext-link-type="uri" xlink:href="http://www.elifesciences.org/the-journal/review-process">review process</ext-link>). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.</p></boxed-text><p>Thank you for sending your work entitled “α-Synuclein Induces Synaptic Vesicle Clustering Via Binding To Phospholipids and Synaptobrevin-2/VAMP2” for consideration at <italic>eLife</italic>. Your article has been favorably evaluated by a Senior editor and 3 reviewers, one of whom is a member of our Board of Reviewing Editors.</p><p>The following individuals responsible for the peer review of your submission want to reveal their identity: Reinhard Jahn (Reviewing editor), and Jose Rizo and Yeon-Kyun Shin (peer reviewers).</p><p>The Reviewing editor and the other reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.</p><p>1) The concentration of synuclein used in the experiments is very high (2–20 μM), resulting in high protein:lipid ratios, raising the possibility that the liposomes are completely covered with protein. We suggest to carry out experiments testing whether such high concentrations are required. A straightforward option would be to run dynamic light scattering experiments on mixed liposome solutions using increasing concentrations of synuclein, but other approaches addressing the same problem are also acceptable.</p><p>2) A second related question is whether vesicle aggregation is caused by homooligomerization of synuclein between membranes. While we realize that this question may not be trivial to address, one possible option is to pre-incubate the docked vesicles with synuclein, wash away any unbound material, and then test whether synaptobrevin-liposomes still bind. Although such experiments would not be completely conclusive (particularly if the outcome is negative), this question should be approached by such or other suitable experiments.</p><p>3) All referees had difficulties with your model that seems highly speculative and almost counter-intuitive: the data presented in the paper actually show a reduction of docking between v-vesicles and t-vesicles by addition of α-synuclein. If this model is correct, wouldn't one expect a substantial effect of synucleing KO on neurotransmitter release? See the recent paper by Choi et al. (<italic>PNAS</italic>, Feb 19 2013), where the authors argue that vesicle clustering by large α-synuclein oligomers inhibit vesicle fusion and reduce neurotransmitter release.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.00592.014</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><p><italic>1) The concentration of synuclein used in the experiments is very high (2–20 μM), resulting in high protein:lipid ratios, raising the possibility that the liposomes are completely covered with protein. We suggest to carry out experiments testing whether such high concentrations are required. A straightforward option would be to run dynamic light scattering experiments on mixed liposome solutions using increasing concentrations of synuclein, but other approaches addressing the same problem are also acceptable</italic>.</p><p>Unfortunately, dynamic light scattering experiments did not produce statistically meaningful results due to the relatively small effect of small numbers of vesicles clustering in such bulk experiments. However, we would like to point out that the effective concentration in our single vesicle clustering experiments (new Figures 3 and 4) is lower than 2–20 μM. The reason is that α-Syn was added after surface immobilization of acceptor DiD-labeled v-vesicles at 2–20 μM; after the incubation, unbound α-Syn was washed away by buffer exchange. Moreover, it is likely that the buffer exchange also removed some of the v-vesicle-bound α-Syn molecules since kinetic studies by NMR spectroscopy revealed that α-Syn binding to membranes is transient with exchanges occurring in the range of 1–10 s (Bodner et al., 2009). Then, donor DiI-labeled v-vesicles were injected in the absence of free α-Syn. Indeed, as Figure 4A shows, v-vesicle clustering has not reached saturation at 2 μM α-Syn incubation concentration. We added a new illustration (Figure 3B), along with a discussion of this point in the Results section.</p><p><italic>2) A second related question is whether vesicle aggregation is caused by homooligomerization of synuclein between membranes. While we realize that this question may not be trivial to address, one possible option is to pre-incubate the docked vesicles with synuclein, wash away any unbound material, and then test whether synaptobrevin-liposomes still bind. Although such experiments would not be completely conclusive (particularly if the outcome is negative), this question should be approached by such or other suitable experiments</italic>.</p><p>We apologize that the description of our protocol was somewhat hidden in the Materials and methods section. We therefore added the above-mentioned new Figure 3B. Indeed, we already did what the reviewers suggested by removing unbound α-Syn prior to adding free v-vesicles to the surface-mmobilized v-vesicles. Furthermore, we have measured α-Syn mediated liposome clustering with liposomes that either contain synaptobrevin-2, or lack synaptobrevin-2 (Figure 4A). Only in the former case did we observe significant v-vesicle clustering, whereas in the absence of synaptobrevin-2, no clustering was observed. Thus, v-vesicle clustering is not caused by homo-oligomerization of α-Syn, but requires specific binding of α-Syn to synaptobrevin-2, as well as binding to anionic lipids.</p><p><italic>3) All referees had difficulties with your model that seems highly speculative and almost counter-intuitive: the data presented in the paper actually show a reduction of docking between v-vesicles and t-vesicles by addition of α-synuclein. If this model is correct, wouldn't one expect a substantial effect of synucleing KO on neurotransmitter release? See the recent paper by Choi et al. (PNAS, 19 Feb 2013), where the authors argue that vesicle clustering by large α-synuclein oligomers inhibit vesicle fusion and reduce neurotransmitter release</italic>.</p><p>We apologize that our explanation was unclear. To better explain the observed reduction of fluorescent spots in the v-/t-vesicle fusion experiments, we performed an analysis of the distribution of the fluorescence intensities of the observed fluorescent spots (new Figure 2B). The major peak (&lt;1.5 a.u.) at low florescence intensity corresponds to single donor v-vesicles docked to the imaging surface, while the high intensity tail (&gt;2 a.u.) corresponds to small clusters (doubles, triples, …) of v-vesicles docked to the surface. In the presence of α-Syn, we observed a reduction of the low intensity population and a concomitant increase of higher intensity spots (Figure 2B, insert), along with a few very large spots (arrow in lower right image in Figure 2A). This observation implies the formation of v-vesicle clusters, resulting in a decrease of particle number in the finite volume of our system since the initial concentration of individual v-vesicles is identical for both experiments. A new illustration (Figure 2C) has been added to better illustrate this point. Moreover, we would like to note that extensive studies performed in our and in Pablo Castillo's laboratory failed to observe an effect of the α/β-synuclein double KO and the α/β/γ-synuclein triple KO mice on neurotransmitter release (see Chandra et al., PNAS 2004; Burre et al., Science 2010). Our model does not necessitate a role for α-Syn in regulating release, consistent with the actual physiological results.</p></body></sub-article></article>